[Congressional Record Volume 168, Number 57 (Thursday, March 31, 2022)]
[House]
[Pages H4023-H4033]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




    PROVIDING FOR CONSIDERATION OF H.R. 3617, MARIJUANA OPPORTUNITY 
 REINVESTMENT AND EXPUNGEMENT ACT; PROVIDING FOR CONSIDERATION OF H.R. 
        6833, AFFORDABLE INSULIN NOW ACT; AND FOR OTHER PURPOSES

  Mr. PERLMUTTER. Mr. Speaker, by direction of the Committee on Rules, 
I call up House Resolution 1017 and ask for its immediate 
consideration.
  The Clerk read the resolution, as follows:

                              H. Res. 1017

       Resolved, That upon adoption of this resolution it shall be 
     in order to consider in the House the bill (H.R. 3617) to 
     decriminalize and deschedule cannabis, to provide for 
     reinvestment in certain persons adversely impacted by the War 
     on Drugs, to provide for expungement of certain cannabis 
     offenses, and for other purposes. All points of order against 
     consideration of the bill are waived. In lieu of the 
     amendment in the nature of a substitute recommended by the 
     Committee on the Judiciary now printed in the bill, an 
     amendment in the nature of a substitute consisting of the 
     text of Rules Committee Print 117-37, modified by the 
     amendment printed in part A of the report of the Committee on 
     Rules accompanying this resolution, shall be considered as 
     adopted. The bill, as amended, shall be considered as read. 
     All points of order against provisions in the bill, as 
     amended, are waived. The previous question shall be 
     considered as ordered on the bill, as amended, and on any 
     further amendment thereto, to final passage without 
     intervening motion except: (1) one hour of debate equally 
     divided and controlled by the chair and ranking minority 
     member of the Committee on the Judiciary or their respective 
     designees; (2) the further amendments described in section 2 
     of this resolution; and (3) one motion to recommit.
       Sec. 2.  After debate pursuant to the first section of this 
     resolution, each further amendment printed in part B of the 
     report of the Committee on Rules shall be considered only in 
     the order printed in the report, may be offered only by a 
     Member designated in the report, shall be considered as read, 
     shall be debatable for the time specified in the report 
     equally divided and controlled by the proponent and an 
     opponent, may be withdrawn by the proponent at any time 
     before the question is put thereon, shall not be subject to 
     amendment, and shall not be subject to a demand for division 
     of the question. All points of order against the further 
     amendments printed in part B of the report of the Committee 
     on Rules are waived.
       Sec. 3.  Upon adoption of this resolution it shall be in 
     order to consider in the House the bill (H.R. 6833) to amend 
     title XXVII of the Public Health Service Act, the Internal 
     Revenue Code of 1986, and the Employee Retirement Income 
     Security Act of 1974 to establish requirements with respect 
     to cost-sharing for certain insulin products, and for other 
     purposes. All points of order against consideration of the 
     bill are waived. An amendment in the nature of a substitute 
     consisting of the text of Rules Committee Print 117-38, 
     modified by the amendment printed in part C of the report of 
     the Committee on Rules accompanying this resolution, shall be 
     considered as adopted. The bill, as amended, shall be 
     considered as read. All points of order against provisions in 
     the bill, as amended, are waived. The previous question shall 
     be considered as ordered on the bill, as amended, and on any 
     further amendment thereto, to final passage without 
     intervening motion except: (1) one hour of debate equally 
     divided among and controlled by the respective chairs and 
     ranking minority members of the Committees on Education and 
     Labor, Energy and Commerce, and Ways and Means, or their 
     respective designees; and (2) one motion to recommit.
       Sec. 4.  House Resolution 188, agreed to March 8, 2021 (as 
     most recently amended by House Resolution 900, agreed to 
     February 2, 2022), is amended by striking ``April 1, 2022'' 
     each place it appears and inserting (in each instance) 
     ``April 29, 2022''.

  The SPEAKER pro tempore. The gentleman from Colorado is recognized 
for 1 hour.
  Mr. PERLMUTTER. Mr. Speaker, for the purpose of debate only, I yield 
the customary 30 minutes to the gentlewoman from Minnesota (Mrs. 
Fischbach), pending which I yield myself such time as I may consume. 
During consideration of this resolution, all time yielded is for the 
purpose of debate only.


                             General Leave

  Mr. PERLMUTTER. Mr. Speaker, I ask unanimous consent that all Members 
may have 5 legislative days in which to revise and extend their 
remarks.
  The SPEAKER pro tempore. Is there objection to the request of the 
gentleman from Colorado?
  There was no objection.
  Mr. PERLMUTTER. Mr. Speaker, I yield myself such time as I may 
consume.
  Mr. Speaker, the Rules Committee met and reported a rule, House 
Resolution 1017, providing for consideration of two bills. The rule 
provides for consideration of H.R. 3617, the MORE Act, under a 
structured rule. The rule self-executes a manager's amendment from 
Chairman Nadler, provides 1 hour of debate equally divided and 
controlled by the chair and ranking minority member of the Committee on 
the Judiciary, makes three amendments in order, and provides one motion 
to recommit.
  The rule also provides for consideration of H.R. 6833, the Affordable 
Insulin Now Act, under a closed rule. The rule self-executes a 
manager's amendment from Chairwoman DeLauro, provides 1 hour of debate 
equally divided among and controlled by the chairs and ranking minority 
members of the Committees on Education and Labor, Energy and Commerce, 
and Ways and Means, and provides one motion to recommit.
  Finally, the rule extends recess instructions, suspension authority, 
and same-day authority through April 29, 2022.
  Mr. Speaker, I am pleased we are here today to provide for 
consideration of Chairman Nadler's MORE Act, which would end decades of 
failed and unjust marijuana policy.
  Today, 18 States, two territories, and the District of Columbia have 
laws legalizing and regulating commercial cannabis, and a total of 37 
States, three territories, and the District of Columbia have laws 
allowing cannabis for medical purposes. An additional 11 States have 
low-THC medical cannabis laws.
  This means a total of 47 States, four territories, and the District 
of Columbia have laws allowing some use of cannabis; 97.7 percent of 
the U.S. population live in these States and territories. It is clear 
Prohibition is over.
  Today we have an opportunity to chart a new path forward on Federal 
cannabis policy that actually makes sense. The MORE Act is about 
justice, safety, equity, and States' rights. The bill would 
decriminalize cannabis at the Federal level by removing the substance 
from the Controlled Substances Act, but the bill does not force a State 
to legalize any form of cannabis. It is still up to the States to set 
their own policy.
  The bill also contains provisions on resentencing and the expungement 
of criminal records. There is no reason why people should still be in 
prison for low-level, nonviolent cannabis convictions, or have their 
future predetermined by a cannabis conviction. The war on drugs has 
torn many families and communities apart and has had a disproportionate 
impact on people of color. The MORE Act would allow communities to 
start the healing process.
  By removing cannabis from the Controlled Substances Act, the bill 
also addresses the cannabis banking problem that I have been working on 
for nearly

[[Page H4024]]

10 years in the form of the SAFE Banking Act. Under current law, banks 
and credit unions providing services to State-licensed cannabis 
businesses are subject to criminal prosecution and regulatory penalties 
under Federal law. Therefore, businesses which legally grow, market, or 
sell cannabis in States where it is legal are generally locked out of 
the banking system, making it difficult for them to maintain a checking 
account, access credit, accept credit and debit cards, meet payroll, or 
pay tax revenue.
  This has created a significant public safety risk, as these 
businesses are forced to operate as cash-only businesses in an industry 
with billions and billions of dollars in transactions. These high-
volume cash businesses are being targeted by violent criminals and 
putting our communities at risk.
  I want to share a few examples of how bad the public safety issue has 
become.
  In November 2021, over the course of one week in Oakland, California, 
more than 25 cannabis businesses had their stores vandalized and robbed 
and lost upwards of $5 million.
  A Colorado dispensary chain saw 15 burglaries during a 90-day period 
in mid-2021, with criminals driving vehicles into their buildings, 
cutting holes through rooftops and walls, and attacking the stores with 
pry bars and sledgehammers.
  Washington State is averaging more than a robbery per day at 
dispensaries. In fact, recently in The Seattle Times, it was reported 
that there were three deaths related to robberies of dispensaries--the 
robber, a policeman, and owner of a store. This is just last week.
  This is an untenable situation for these businesses, their employees, 
and their customers. If Congress fails to align Federal and State law, 
crimes targeting dispensaries will only get worse. The cannabis 
industry remains one of the fastest-growing industries and now supports 
more than 428,000 jobs, with nearly $25 billion in State-legal cannabis 
sales per year. The time to pass the MORE Act and right the injustices 
in our community is now.
  This rule also provides for consideration of H.R. 6833, the 
Affordable Insulin Now Act, to address skyrocketing insulin costs. Over 
37 million Americans have been diagnosed with diabetes, and in Colorado 
there are over 300,000. The Affordable Insulin Now Act will require 
Medicare Part D and health insurance plans to cover insulin and cap 
out-of-pocket cost-sharing at $35 per month.
  Prescription drugs like insulin force Coloradans to make difficult 
financial decisions. In a 2020 report from the Colorado Attorney 
General, approximately 40 percent of all survey respondents reportedly 
using insulin are forced to ration their use of this lifesaving product 
at least once a year.

                              {time}  1230

  I am proud of the steps Colorado has taken to ensure individuals have 
greater access to insulin. In 2021, Colorado became the second State in 
the country to limit insulin prices by enacting an insulin 
affordability program.
  No one should have to pay more than $35 a month for insulin. The 
passage of this legislation will lower costs for insulin users and save 
money for hardworking Americans. I commend Representative Angie Craig 
and all of my colleagues for their work on this bill.
  I urge all of my colleagues to support the rule and the underlying 
bills, and I reserve the balance of my time.
  Mrs. FISCHBACH. Mr. Speaker, I thank the Representative from Colorado 
for yielding me the customary 30 minutes, and I yield myself such time 
as I may consume.
  Today, we are here to consider House Resolution 1017, a rule 
providing for consideration of H.R. 6833 and H.R. 3617. This rule makes 
in order no Republican amendments, completely ignoring the flaws of 
each underlying bill and the thoughtful concerns raised by my 
colleagues. Not only do my colleagues not want to debate these issues, 
but they also don't appear to even want to acknowledge them.
  First, I want to address H.R. 6833, the Affordable Insulin Now Act, 
which would require health insurers to cover selected insulin products 
without applying any deductible or imposing any cost-sharing in excess 
of $35.
  This bill is just a partisan exercise that will only reshuffle the 
decks for how patients pay for insulin. It is not a serious attempt to 
address rising prices. The price controls in this legislation would be 
an expansive intervention into the free market and will most likely 
lead to an increase in premiums for everyone.
  Let's not forget, one of the reasons drug prices are rising is 
because of Washington and the majority's runaway spending leading to 
the greatest deficits in American history. Instead of admitting that 
their wildly expensive spending bills have caused inflation, my 
colleagues claim that companies have suddenly decided now is the time 
to raise prices arbitrarily.
  Congress cannot keep dumping money into the economy and then blaming 
American companies for the problems it creates. We need to be focusing 
on getting our debt under control and stop the war on American industry 
so that we can reduce prices not just on drugs but on everything.
  Furthermore, addressing only insulin establishes a problematic 
precedent and fails to take into account the high prices associated 
with countless other necessary drugs, like those for cancer, heart 
disease, and a slew of other conditions.
  A sincere attempt by Congress to solve this problem would be to focus 
on ways to reduce pricing through market-based forces. For example, 
Republicans on the Energy and Commerce Committee have offered several 
proposals which would improve price transparency so that Americans 
could see the real cost of their drugs and make choices accordingly.
  Instead of working with Republicans to advance these solutions, the 
majority has yet again elected a go-it-alone approach that has yet to 
achieve any results for the American people.
  Next is H.R. 3617, the Marijuana Opportunity Reinvestment and 
Expungement Act, a broad bill that would remove pot from the list of 
scheduled substances under the Controlled Substances Act and eliminate 
criminal penalties for individuals who manufacture, distribute, or 
possess marijuana. This rule makes no Republican amendments in order, 
which is proof that the Democrats just want to push this bill as a 
messaging bill.
  That said, there are several concerns with this bill. First, it fails 
to set any standards to prevent marijuana use by those most vulnerable 
to abuse: minors. In fact, back in September, when Mr. Fitzgerald 
offered an amendment to alter the definition of the term ``minor'' to 
align with other provisions of U.S. Code, the majority voted against 
it.
  Without this amendment, crucial protections for our youth are left 
out of this bill. In committee, I even offered a motion to consider an 
amendment that would maintain existing penalties for selling pot to 
minors. It was defeated along party lines, a stunning position for 
Democrats to take.
  But not only does this bill legalize pot; it creates a new government 
program to assist people in opening pot stores. Let me repeat that: 
This bill creates a government program to help people open pot stores.
  This bill also ignores the issue of driving under the influence, even 
though driving under the influence of marijuana can have deadly 
consequences, something law enforcement officers across America have 
warned about.
  Additionally, what happens if an illegal immigrant is arrested for 
driving under the influence of marijuana? This is not addressed.
  Republicans on the committee sought to ensure that this bill would 
not impede the deportation of illegal immigrants who have been arrested 
for driving under the influence. That was also rejected along party 
lines.
  There are so many issues our constituents are facing today. Yet, we 
are here, spending time considering legislation to legalize pot that is 
not only flawed, but it is also dangerous.
  We could be working on lowering gas prices, tackling the snowballing 
Federal debt, or addressing the inflation affecting every American 
today. But instead, I guess the majority wants us to get as high as 
today's gas prices and spend tax dollars on pot stores.
  Mr. Speaker, I oppose the rule and the underlying bill. I ask Members 
to do the same, and I reserve the balance of my time.
  Mr. PERLMUTTER. Mr. Speaker, I yield myself such time as I may 
consume.

[[Page H4025]]

  I remind my friend from Minnesota who was talking about party-line 
votes, we want to bring down the cost of prescription drugs, whether it 
is insulin or across the board, which we have done in the Build Back 
Better bill that is sitting in the Senate, and I can say I 
think virtually every single Republican voted against negotiating 
prescription drug prices.

  If you want to talk about a free market, then you ought to be able to 
negotiate prescription drug prices so that Americans across the board 
get the best possible prices for their drugs.
  Mr. Speaker, I yield 2 minutes to the gentleman from New York (Mr. 
Morelle), a prominent and distinguished member of the Rules Committee.
  Mr. MORELLE. Mr. Speaker, I thank the distinguished and, by his own 
admission, highly caffeinated gentleman from Colorado (Mr. Perlmutter), 
my Rules Committee colleague and great friend, for yielding me time.
  I rise today in support of the rule and the underlying legislation. 
In particular, I would like to say a few words about the Affordable 
Insulin Now Act.
  Over the past two decades, the costs of prescription diabetes drugs 
like insulin have artificially skyrocketed by more than tenfold.
  A few years ago, I was proud to commission a report by the House 
Committee on Oversight and Reform to determine the extent of this price 
gouging and how it is affecting communities across the country, 
including my own in Rochester, New York, and the impact it is having on 
patients, especially older adults, and our uninsured population. The 
results of that review were staggering.
  In communities across the country, out-of-pocket costs have risen by 
400 percent for the Medicare program and beneficiaries over the last 
decade. The average price for a standard unit of insulin in the United 
States was more than 10 times the average price in a sampling of 32 
other countries.
  These excessively inflated prices have real consequences on how 
patients manage this chronic disease. I have talked with many patients 
and families in my own district that have had to ration their dose or 
stop taking this lifesaving and life-sustaining medication altogether.
  For the richest and most powerful nation in the world to allow this 
to continue is nothing less than shameful.
  In passing this bill, we are taking the first step of many to rein in 
these inflated costs and protecting patients to ensure the best 
possible health outcomes.
  I am so proud to deliver for my constituents back home, and I look 
forward to voting for this rule and getting one step closer toward 
seeing the bill passed into law.
  Mrs. FISCHBACH. Mr. Speaker, I yield myself such time as I may 
consume.
  Mr. Speaker, if we defeat the previous question, I will offer an 
amendment to the rule to provide for consideration of Congresswoman 
McMorris Rodgers and Congressman Westerman's American Energy 
Independence from Russia Act.
  Mr. Speaker, I ask unanimous consent to include the text of my 
amendment in the Record, along with extraneous material, immediately 
prior to the vote on the previous question.
  The SPEAKER pro tempore. Is there objection to the request of the 
gentlewoman from Minnesota?
  There was no objection.
  Mrs. FISCHBACH. Mr. Speaker, while the majority is continuing to 
prioritize things like legalizing marijuana, constituents in my 
district continue to send me photos of their energy bills and the 
prices they are paying at the gas pumps.
  Since President Biden took office, gasoline prices are up by more 
than 50 percent, natural gas is up more than 25 percent, and diesel 
fuel is up more than 47 percent. These price increases are on top of 
crippling, record-high inflation that is a tax on the American people 
of every stripe, class, and creed.
  When adjusted for these factors, wages and salaries are below 
prepandemic levels. My constituents are pleading with Congress to focus 
on this issue and are being ignored by the out-of-touch majority.
  Mr. Speaker, to speak further on the previous question, I yield 3 
minutes to the gentleman from Oklahoma (Mr. Hern).
  Mr. HERN. Mr. Speaker, I rise to oppose the previous question so that 
we can immediately consider H.R. 6858.
  This administration has sent desperate requests for oil from 
oppressive regimes like Iran and Venezuela. It is past time the Biden 
administration start making those frantic calls to Oklahoma instead of 
OPEC or even my friends in Texas instead of Tehran. Until that happens, 
gas prices will continue to soar, and hardworking Americans will 
suffer.
  While Putin continues to wage war on Ukraine, exposing our dependence 
on Russian energy, Biden continues to wage war on our domestic oil and 
gas industry that provides sustainable, reliable energy to the American 
people.
  This week, Biden doubled down his attack by releasing a budget that 
includes an astonishing $45 billion in tax hikes on American energy 
producers.
  Seventy percent of goods in America are moved by trucks. An increase 
in gas prices will continue to be passed down on the food and products 
that all Americans buy. Let me be clear: Biden's energy policy is 
hurting all Americans and not just at the pump.
  Whether you like it or not, traditional energy powers our country. 
Oil and gas are essential to power our homes and, yes, provide the 
energy to power electric vehicles.
  Biden's war on energy poses a threat to all of us. It is imperative 
that the Federal Government stop villainizing the industry that powers 
our world.
  Global energy markets are complicated, but one thing is certain: If 
policymakers continue to impose barriers on domestic energy production, 
prices will continue to rise. Therefore, we need to instill confidence 
in the industry that plays such a crucial role in our economy by 
restoring stability and consistency with policies that prioritize 
American energy production.
  Investors and business leaders make their decisions based not only on 
the policies debated and voted on in D.C. but also on the rhetoric from 
public officials. What happens in this Chamber impacts businesses, but 
also what we go out and say on cable TV.

  Trust me, I was a business leader for 35 years. Today's political 
climate will directly influence future investment decisions, especially 
in heavily regulated industries like energy.
  The Biden administration has been sending mixed messages. My 
colleagues on the other side of the aisle say they are concerned about 
the high prices reflected by the weak oil and gas supply, but their 
actions tell a different story. They aggressively push a plan to crush 
oil and gas production entirely.
  Their video simply doesn't match their audio, which is why the 
American people have lost faith in Democratic leadership.
  We must restore sanity and pursue energy dominance once again on the 
world stage.
  Mr. PERLMUTTER. Mr. Speaker, I yield myself such time as I may 
consume.
  Mr. Speaker, just a couple points in response.
  One, we are trying to bring down the price of insulin--that is one of 
the bills here that we are talking about--from the outrageous amounts 
that are required for this lifesaving drug down to $35. Yet, my 
Republican colleagues oppose reducing that.
  They worry about inflation at the pump, which we all do, but it is 
Putin's price hike. We know where this came from, this increase, and 
the President is working to release millions of barrels of oil from our 
underground storage, and he wants to place a price on leases that 
aren't being used. We have 12 million acres that are under lease and 
are not being used. That will bring down the price at the pump. But we 
have to defeat Putin. It is his price hike.
  Mr. Speaker, I yield 5\1/2\ minutes to the gentleman from 
Massachusetts (Mr. McGovern), the chairman of the Rules Committee.

                              {time}  1245

  Mr. McGOVERN. Mr. Speaker, I rise today to recognize someone who has 
made a truly exceptional contribution to this institution and to the 
work that goes on here, the amazing Peggy Fields.
  Peggy has served in the Clerk's Office since 2008, first as assistant 
bill clerk and now as bill clerk, where she oversees an amazing team 
that works late

[[Page H4026]]

nights and long hours to literally keep the House of Representatives 
running.
  I can spend hours talking about how incredible everyone in the 
Clerk's Office is:
  How they have an incredible eye for detail and never drop the ball;
  How they seamlessly process the hundreds of daily submissions into 
the hopper;
  How they rose to the challenge of keeping this body running during a 
pandemic--implementing proxy voting and the e-hopper so our work could 
go on, even when it wasn't safe for all of us to be here;
  And, of course, how much they believe in this institution and all 
that it represents.
  But I only have a few minutes, so let me just say to everyone in the 
Clerk's Office that your work does not go unnoticed. It is recognized 
by so many of us here in the congressional community and beyond.
  Mr. Speaker, Peggy Fields started her journey to Capitol Hill 33 
years ago when she went to work for former Congressman ``Bud'' Cramer, 
who was then the district attorney of Madison County, Alabama.
  Congressman Cramer told me that when he was sworn into Congress in 
January 1991, the first employee in his Washington office was Peggy 
Fields. Peggy helped run that office for 18 years, and unsurprisingly, 
she was beloved by everyone. In the Congressman's office, Peggy proudly 
represented her hometown of Huntsville, Alabama.
  He told me that Peggy and her family are renowned in Huntsville, and 
that she is and always has been devoted to the people of Huntsville, as 
well as her friends and family back home.
  In 2008, she joined the Office of the Clerk as an assistant bill 
clerk. And her dedication and exceptional work ethic earned her the 
promotion to bill clerk in July of 2021.
  As if all this were not enough, Peggy will soon graduate from Wesley 
Theological Seminary with a doctorate of ministry degree in church 
leadership. And I want to congratulate her on that incredible 
achievement.
  Peggy and her team have the daunting task of processing every single 
bill and cosponsor form for the House.
  Mr. Speaker, as you know, the bill clerks work especially closely 
with the Parliamentarian's office, because the Parliamentarian is 
responsible for referring all bills on the day that they are 
introduced. And the bill clerks process those referrals on the same day 
as well.
  Now, sometimes that means that the bill clerks and Parliamentarians 
share late nights together and they get to know each other quite well. 
I want to read a note sent over to me by the Parliamentarian's office 
about Peggy.
  ``Peggy is always such a welcoming presence to us, both on the floor 
and in our offices. However, Peggy is so welcoming and kind that there 
is always a noticeable uptick in bill introduction whenever she is 
stationed on the floor. That is why we came to know her by the nickname 
`The Bill Magnet,' we know that our workload increases whenever she is 
on the floor.
  ``However, always thinking of others, Peggy would make up for this 
increased bill count by singing a cappella renditions of popular songs 
in our office while we finished up our referrals. She is one of a kind, 
the consummate public servant, and truly irreplaceable to this 
institution.''
  Mr. Speaker, at a time when there are a lot of challenges and 
uncertainties in the world, here is someone who is doing everything she 
can to make everyone's day a little bit brighter and to give back to 
her community and to her country; someone who, through her dogged 
willpower, incredible knowledge, and decades of experience, tackles 
every challenge she faces with poise, talent, and a great sense of 
humor.
  Even on her team's busiest days, during their longest hours, and on 
their latest nights, and during the historic and often unprecedented 
times that we are living through, Peggy is a beacon of light, bringing 
camaraderie and positivity to everything she does.
  She has served this institution, and the people it represents, with 
integrity, with honor, and with skill for the past 33 years.
  Mr. Speaker, Peggy Fields is an inspiration, and her career in public 
service has been nothing short of remarkable. She set out to make a 
difference, and what a difference she has made.
  On behalf of all of my colleagues and staff on both sides of the 
aisle, past and present, and the countless people in whose lives Peggy 
has made an immeasurable difference, I would like to extend this 
institution's deepest and most sincere thanks to Peggy and wish her all 
the best as she begins this new chapter.
  Thank you, Peggy.
  Mr. PERLMUTTER. Mr. Speaker, I reserve the balance of my time.
  Mrs. FISCHBACH. Mr. Speaker, I join the gentleman from Massachusetts 
and the entire body in congratulating Ms. Fields on her retirement and 
thank her for her service.
  Mr. Speaker, I yield 2 minutes to the gentleman from Pennsylvania 
(Mr. Joyce).
  Mr. JOYCE of Pennsylvania. Mr. Speaker, I rise in opposition to the 
previous question so that we can immediately consider H.R. 6858, the 
American Energy Independence from Russia Act.
  As Congress debates legalizing marijuana, Americans in the real world 
are facing an energy crisis that we in Congress cannot afford to 
continue to ignore.
  In my hometown of Altoona, Pennsylvania, the cost of gasoline is now 
$4.28 a gallon; over 50 percent higher than it was just one year ago.
  In rural communities, these skyrocketing prices are forcing families 
to make hard choices about what they can afford and what they cannot 
afford. Instead of working to support the needs of these Pennsylvanian 
families, President Biden and his administration have continued to work 
against American energy producers.
  On day one of his Presidency, President Biden made good on a longtime 
liberal wish list item. He canceled the Keystone XL pipeline. Now, in 
his budget, President Biden has chosen to put solar panels ahead of 
natural gas. He has chosen to put windmills ahead of coal. He has 
chosen the Green New Deal ahead of Pennsylvanians.
  Now, the President has decided to recklessly release oil from our 
strategic reserves without a concrete plan to refill them. This stopgap 
measure does not support our national security and it will do little to 
help lower the cost of fuel for American families.
  It is time to invest in American energy. It is time to return to 
American energy dominance.
  Mr. Speaker, I urge my colleagues to vote ``no'' on the previous 
question.
  Mr. PERLMUTTER. Mr. Speaker, we are here about reducing prices on 
insulin, something that so many Americans need. Yet, my colleagues want 
to talk about a bill that is not even before the House of 
Representatives today. We ought to be talking about reducing the price 
of prescription drugs, like insulin, for Americans who need it.
  Mr. Speaker, I yield 2 minutes to the gentlewoman from Pennsylvania 
(Ms. Scanlon), my friend, and another prominent member of the Committee 
on Rules.
  Ms. SCANLON. Mr. Speaker, I thank Representative Perlmutter for 
yielding.
  Mr. Speaker, I rise in strong support of today's rule. The two bills 
in the rule provide for important, long overdue reforms that most 
Americans are in favor of. The MORE Act will reform our Federal drug 
laws to bring Federal laws in line with the majority of States which 
are now legally and responsibly regulating cannabis.
  Mr. Speaker, 37 States, including the Commonwealth of Pennsylvania, 
have successfully legalized medicinal cannabis, creating a thriving, 
safe, and legal market for cannabis, creating thousands of jobs and 
billions in new tax revenue. This is a rare win-win scenario for 
everyone--government, businesses, patients, and consumers.
  However, the ongoing conflict between our State and Federal laws 
creates daily legal issues for businesses, banks, doctors, and 
consumers. The MORE Act will address these problems by removing 
cannabis from the Controlled Substances Act. This will allow veterans 
to use medicinal cannabis without losing their VA benefits.
  It will allow legal businesses to access financial services. It will 
allow scientists and government agencies to research cannabis, and it 
will not prevent States from regulating or even criminalizing misuse of 
cannabis.

[[Page H4027]]

  More importantly, the MORE Act includes a comprehensive package of 
criminal justice reforms to give a second chance to those whose lives 
have been upended by the excesses of the war on drugs.
  Mr. Speaker, today's rule also includes the Affordable Insulin Now 
Act, which will cap insulin costs at $35. This is a much-needed reform 
that will provide financial relief to the millions of Americans who 
rely on insulin to manage their diabetes. While I am glad that we are 
able to find compromise on capping insulin costs, Americans are 
demanding that we pass comprehensive legislation to lower prescription 
drug costs for all Americans. And we continue to invite our Republican 
colleagues to help us to do that.
  Prescription drug prices are way too high. Insulin is ten times more 
expensive in the U.S. than in other countries. Across the board, 
Americans pay more for their drugs than people in other countries pay 
for the exact same drugs. There is no justification for this 
difference.
  The SPEAKER pro tempore. The time of the gentlewoman has expired.
  Mr. PERLMUTTER. Mr. Speaker, I yield an additional 30 seconds to the 
gentlewoman.
  Ms. SCANLON. Mr. Speaker, the prescription drug market is broken, and 
insulin is just one example of how bad the problem is. We urgently need 
prescription drug price reform so all Americans can afford the 
medications they need to manage their health.
  Mr. Speaker, I urge all of my colleagues to vote for today's rule and 
the underlying bills when they are considered on the floor.
  Mrs. FISCHBACH. Mr. Speaker, I yield 3 minutes to the gentlewoman 
from Colorado (Mrs. Boebert).
  Mrs. BOEBERT. Mr. Speaker, I thank the gentlewoman from Minnesota for 
yielding.
  Mr. Speaker, I rise today to urge my colleagues to defeat the 
previous question so that we can immediately consider the American 
Energy Independence from Russia Act.
  Gas prices are at $5 and even $6 a gallon. The average household is 
now spending $2,000 more a year because of increased gas costs on 
Biden's watch. Biden and the Democrats think that now is the time to 
add $45 billion in new taxes on the oil and gas industry. Many 
Americans have been and are being regulated into poverty in an 
unnecessary sacrifice at the altar of climate change.
  Instead of unleashing our domestic oil and gas industry, Biden is 
``simp'' to radical environmentalists and not-in-my-backyard 
extremists, and literally begged OPEC to drill more oil instead of 
relying on the hardworking American roughneck.
  On day one, he canceled the Keystone XL pipeline, killing 11,000 
good-paying American energy jobs. But that didn't stop the big guy from 
approving the Nord Stream 2 pipeline and benefitting our enemies.
  Because of Biden's fake ban on Russian oil and gas, that won't even 
go into effect for 22 more days and is littered with waivers to keep 
Russian energy flowing, the U.S. continues to import 100,000 barrels of 
Russian oil and send them roughly $10 million each day. We folks are 
funding the Kremlin.
  Why does Biden favor foreign energy over domestic energy? We know 
that American natural gas is 42 percent cleaner than Russian gas, so it 
is not for environmental reasons. But maybe there is another reason we 
don't know about. Perhaps there is 10 percent in this tucked away for 
the big guy.
  How about this: Instead of funding both sides of the war and playing 
Biden and Pelosi's con games, we should restart construction of the 
Keystone XL pipeline, overturn Biden's energy leasing moratorium, and 
expedite permits for pipelines and natural gas exports.
  We need the American Energy Independence from Russia Act and stop 
playing Biden's energy-from-anywhere-but-America game.
  Mr. Speaker, America should not only have affordable energy for our 
own use, but we should be exporting it abroad. We can literally export 
strength and freedom to our allies.
  In short, the solution is very simple. Drill, baby, drill.
  The SPEAKER pro tempore. Members are reminded to refrain from 
engaging in personalities toward the President.
  Mr. PERLMUTTER. Mr. Speaker, I yield 90 seconds to the gentleman from 
Texas (Mr. Green).
  Mr. GREEN of Texas. Mr. Speaker, I thank the gentleman for yielding.
  Mr. Speaker, and still I rise. In the richest country in the world, 
we cannot allow healthcare to become wealth care; available to those 
who can afford it.
  Mr. Speaker, this is why I support H.R. 6833, the Affordable Insulin 
Now Act, because diabetes can kill, and insulin can save lives, if you 
can get it.
  Some things bear repeating. Insulin saves lives if you can get it. 
Mr. Speaker, this bill will ensure that millions who need it will be 
able to get it. In the richest country in the world, Mr. Speaker, we 
cannot allow healthcare to be wealth care.

                              {time}  1300

  Mrs. FISCHBACH. Mr. Speaker, I yield 2 minutes to the gentleman from 
Indiana (Mr. Bucshon).
  Mr. BUCSHON. Mr. Speaker, I rise in opposition to the previous 
question so that we can immediately consider H.R. 6858, the American 
Energy Independence from Russia Act.
  Just 1 year ago, our country was comfortably meeting our energy 
needs, and we were a net exporter of energy for the first time in 50 
years. However, under the Biden administration, we have seen a 
continued assault on American energy that has killed jobs, increased 
our dependency on foreign energy sources, and most recently jeopardized 
our national security.
  The administration continues to block new oil and gas lease sales 
from moving forward, all while placing undue regulatory burdens on 
American energy development. Just this week, President Biden proposed 
$45 billion worth of tax increases on fossil fuels in his budget to 
further weaken America's ability to power our country.
  These proposed tax increases are just another example of the 
administration doubling down on the anti-American-produced energy 
policies that have sent prices skyrocketing here at home. The 
administration's energy agenda has not only undermined our country's 
energy security, but has also forced our European allies to become even 
more dependent on Russia to meet their energy needs.
  Instead of turning to America's own energy sector to meet our energy 
needs, this administration is asking countries like Iran and Venezuela 
to compensate for the ban on Russian imports and ignoring American 
energy producers. In doing so, they are prioritizing oil produced by 
dictators over American energy producers who support jobs and 
businesses here at home.
  The administration must reverse course and stop depending on foreign 
dictators to ship oil to the United States.
  Mr. Speaker, now is the time to flip the switch and reduce our 
dependence on foreign energy by unleashing American energy. I urge a 
``no'' vote on the previous question.
  Mr. PERLMUTTER. Mr. Speaker, could I inquire how much time each side 
has remaining?
  The SPEAKER pro tempore. The gentleman from Colorado has 10 minutes 
remaining and the gentlewoman from Minnesota has 13\1/2\ minutes 
remaining.
  Mr. PERLMUTTER. Mr. Speaker, I yield 2 minutes to the gentlewoman 
from Michigan (Ms. Tlaib).
  Ms. TLAIB. Mr. Speaker, I rise in support of the Affordable Insulin 
Now Act and the underlying rule.
  It is unconscionable that in the richest country the planet has ever 
seen, millions of Americans, our neighbors, are forced to choose 
between buying medicine and paying their gas bill. Americans pay more 
than 10 times the price of insulin compared to other similar countries; 
10 times.
  In fact, one in four of our neighbors who rely on insulin have 
rationed or skipped doses due to costs. I want folks to think about 
that. A quarter of the people prescribed insulin for their medical 
condition have risked their life to be able to afford another month's 
worth of insulin. This is shameful.
  Mr. Speaker, H.R. 6833 caps out-of-pocket costs for insulin at no 
more than $35 per month in Medicare and commercial health insurance. 
This cap will be a lifesaver for millions of our neighbors who 
currently pay 10 times more the price of insulin compared to similar 
wealthy nations.
  How can these companies sell the exact same drug here for 10 times 
the

[[Page H4028]]

price of other nations? Because corporate greed and price gouging are 
not just permitted in our country, but encouraged. The bill is not the 
complete fix, Mr. Speaker, and we must do more to help our uninsured. 
So many are hurt and getting sicker and even dying because of corporate 
greed and monopolies of Big Pharma.
  This bill is the beginning in reining in corporate greed and putting 
people over profits. I urge my colleagues to support this bill.
  Mrs. FISCHBACH. Mr. Speaker, I yield 2 minutes to the gentleman from 
Utah (Mr. Moore).
  Mr. MOORE of Utah. Mr. Speaker, I rise to oppose the previous 
question so we can immediately consider H.R. 6858, the American Energy 
Independence from Russia Act.
  I am a proud cosponsor of this bill that will strengthen our energy 
security, bolster our economy, and position ourselves to counter 
Russian aggression in Ukraine.
  This morning, gas near my district office in Ogden, Utah, is $4.30. 
For the average family driving the average vehicle in Utah, this means 
that each fill-up will cost over $110. For Utah's hardworking 
agricultural industry, this means thousands of dollars more will be 
spent on fuel so they can feed the rest of America.
  These skyrocketing prices are unacceptable. I share my constituents' 
outrage over how the Biden administration's policies have contributed 
to this painful situation. This is a self-imposed tax on all Americans. 
For those of us who come from energy producing States, we know we can 
do better.
  It is past time we get back to what we were doing in 2019 when the 
United States was a net exporter of energy. It is better for our 
economy and our environment when we produce domestically. In Utah, we 
understand this because we do this.
  Instead of allowing Americans to do their jobs, the Biden 
administration has shut down new oil and gas leasing. Instead of 
helping our communities grow, he has asked the oil cartels in the 
Middle East to pump more oil. Instead of investing in America, he has 
made us more dependent on energy imports from Russia and other foreign 
adversaries. We can do better.
  Passing the America Energy Independence from Russia Act today will 
put us on a path toward energy independence. I encourage my colleagues 
to join me in rejecting the previous question so we can lower prices 
for all.

  Mr. PERLMUTTER. Mr. Speaker, I yield 2 minutes to the gentleman from 
Texas (Mr. Doggett).
  Mr. DOGGETT. Mr. Speaker, I support this bill's relief for Mary in 
Austin whose grandson, like so many others, will be able to get some 
relief. They are paying up to $300 per month for insulin, and now they 
would pay $35 per month.
  But 5\1/2\ million Texans and 28 million Americans are uninsured. 
This bill offers them no help whatsoever. In our upside-down healthcare 
system, those who have the least continually get asked to pay the most 
for essential pharmaceuticals. Sixty-eight percent of those without 
health insurance are forced to pay full monopoly prices for their 
essential insulin. They are being denied any relief today, despite the 
fact that I and 12 of my colleagues offered a simple amendment that 
could have provided that assistance.
  Nor does this bill represent the slightest progress toward preventing 
prescription price gouging. It is so true, as many have said, that many 
Americans are paying 10 times the price for insulin as do consumers in 
other countries. This bill does not do anything, however, to lower it 
to nine times. Indeed, this bill does not lower the price of insulin by 
one penny, it just shifts the burden of paying for the insulin off the 
shoulders of insured insulin users, and shifts it on to the rest of us 
who are paying insurance premiums, and will pay higher premiums because 
of this, and $11 billion more in costs to the taxpayers.
  Mr. Speaker, I assume Big Pharma supports this bill because it is not 
facing any additional duty to lower its prices for this lifesaving 
product. Some day this Congress will break free of the shackles of Big 
Pharma, which fills these halls with more lobbyists than there are 
Members of Congress.
  Some day we will provide genuine relief to all Americans burdened by 
soaring drug prices, but that day, sadly, is not today.
  Mrs. FISCHBACH. Mr. Speaker, I yield 2\1/2\ minutes to the gentleman 
from Texas (Mr. Arrington).
  Mr. ARRINGTON. Mr. Speaker, I rise to oppose the previous question so 
that we can immediately consider H.R. 6858, the America Energy 
Independence from Russia Act. That would not only strengthen our 
security and independence, it would lower gas prices by approving the 
Keystone pipeline, removing restrictions on LNG exports, restarting 
production on Federal lands and waters, and overall encouraging more 
American energy development.
  In the midst of skyrocketing inflation and surging prices at the 
pump, along with the geopolitical context where Europe is dependent on 
Russian oil and gas, you would think the Biden administration would 
abandon their whole-of-government approach to targeting American energy 
production. Since Biden took office, he has used every tool at his 
disposal to undermine the oil and gas industry and our energy 
independence along with it.
  In addition to the onslaught of his unilateral attacks, his first 
Presidential budget was released and called for $35 billion in punitive 
tax increases on the oil and gas industry. His administration has 
weaponized and abused their regulatory authority to attack the industry 
at every turn; SEC reports for permitting on the directives, and EPA 
radical regulations.
  What is more astonishing is Biden's latest budget, which is $4 
trillion in taxes, and includes $45 billion in taxes on oil and gas. 
These are the same provisions that his own party rejected and had to 
abandon their build back broke proposal.
  Just like he has done with the regulatory regime, it appears our 
President is weaponizing the tax code to cancel an entire sector of our 
economy, one that is paramount to our prosperity and security. As 
events around the world constrain supply, he seems hellbent to ensure 
that anyone but American energy producers, the most efficient, the 
cleanest producers in the world, are positioned to supply the United 
States and our people and our allies around the world.
  Mr. PERLMUTTER. Mr. Speaker, I remind my friend, Mr. Arrington, that 
there are 12 million acres of nonproducing Federal land with 9,000 
unused but already approved permits for production.
  Mr. Speaker, I would also like to wish Mr. Arrington a happy 
birthday.
  Mr. Speaker, I yield 2 minutes to the gentlewoman from Texas (Ms. 
Jackson Lee).
  Ms. JACKSON LEE. Mr. Speaker, I rise to support H.R. 6833, and I 
acknowledge Ms. Craig and Mrs. McBath. I tell my friends on the other 
side of the aisle that we can walk and chew gum at the same time, but 
right now people are dying because they are apportioning or putting in 
proportion their insulin that they need--not taking the full amount, 
but doing it proportionately. That is a death sentence.

  Let me indicate: Native Americans, 14.7 percent diabetic; Hispanic, 
12.5 percent; Black Americans, 11.7 percent. Many of them are on 
Medicare and many of them are on Medicaid. We can do both. I do rise to 
support this legislation--$35 in 2023, regardless of whether a 
beneficiary has reached the annual out-of-pocket spending; $35 
beginning in 2024.
  It is well-known that those who had diabetes suffered more with 
COVID-19. This is an important step. In the 18th Congressional District 
uninsured residents paid 23 times more for the brand of insulin, and we 
must begin to work on that. I join with my colleagues in making that 
the next step. I rise for this.
  Mr. Speaker, I also rise to support the new response to marijuana, 
and to insist that we pass the MORE Act that came out of my 
subcommittee on the Judiciary Committee.
  Public support for legalization of marijuana has surged in the past 
two decades. A total of 47 States have reformed their laws. We must 
reform the banking aspect of it. We need to open the door to research, 
therapeutic treatment for veterans, better banking and tax laws, and we 
need to help fuel the economic growth within the industry.
  We need to do this by sending dollars out to help our respective 
communities bring down the cost of crime, be able to

[[Page H4029]]

help those who are in business. We must do this and spend Federal 
resources to end criminalization, build the economic engine, and to 
ensure that we are in step with 47 of our States.
  Thousands of men and women have suffered needlessly from the Federal 
criminalization of marijuana with mandatory minimums, particularly 
Black and Brown. All these persons incarcerated need to be able to be 
constructive, but they are in there on the false war on drugs.
  Mr. Speaker, I support both the insulin bill and the MORE Act, and I 
ask my colleagues to support the underlying rule.
  Mr. Speaker, I rise to speak in support of the Rule governing House 
consideration of H.R. 3617, the ``Marijuana Opportunity Reinvestment 
and Expungement Act of 2021,'' or the ``MORE Act of 2021.''
  The Rule that is being considered is carefully crafted and provides 
Members of the House an opportunity to address the existing conflict 
between federal and state laws regarding marijuana, or cannabis, and to 
provide reasonable solutions to resolve this conflict.
  The bill is straightforward and responds to the need to leave the 
question of the legality of cannabis to the individual states while 
attempting to restore and reinvest in communities that have been 
ravaged by the War on Drugs.
  Specifically, the bill decriminalizes cannabis on the federal level, 
provides a taxation structure for the sale of cannabis that will 
support a community reinvestment trust fund, and provides for 
expungement of convictions and arrests for federal cannabis offenses.
  The Rule provides for debate and full consideration of the solutions 
and opportunities for cannabis reform offered by H.R. 3617 by the 
Congress.
  The subject of the bill is public knowledge and well known by members 
of this body.
  I have worked to provide sensible reforms to our criminal justice 
system.
  Our outdated federal laws and policies unwisely require the 
expenditure of scarce law enforcement resources on cannabis offenses 
while conflicting with many states' laws regarding cannabis.
  Cannabis does not fit the definition of a Schedule One drug and 
federal law must be updated to reflect this reality--just as most 
states have already begun to do.
  Thirty-seven states, the District of Columbia, Puerto Rico, and Guam 
have adopted laws allowing medical use of cannabis.
  Eighteen states, the District of Columbia, and the Northern Mariana 
Islands have adopted laws for legalizing cannabis for adult 
recreational use.
  As public support for the legalization of marijuana has surged in the 
past two decades, a total of 47 States have reformed their laws in one 
form or another pertaining to cannabis, despite its federal 
criminalization.
  We need to open the door to research, therapeutic treatment for 
veterans, better banking and tax laws, and we need to help fuel 
economic growth within the industry.
  We need to do this without continuing to spend federal resources on 
criminalization and unjust incarceration for marijuana offenses.
  Thousands of men and women have suffered needlessly from the federal 
criminalization of marijuana, particularly in black and brown 
communities.
  These individuals have borne the burden of collateral consequences 
that have damaged our society across generations--such as the denial of 
affordable housing, educational opportunities, employment, and the 
right to vote.
  Meanwhile, the laws enacted for the purpose of perpetuating the ``War 
on Drugs'' have led America to imprison more people than any other 
country.
  The Rule allows the House to address these historical wrongs by 
voting on H.R. 3617.
  I thank the Committee on the Judiciary, on which I serve, for the 
work it has done to bring H.R. 3617 to the floor for a vote.
  I encourage my colleagues on both sides of the aisle to vote in 
support of the Rule and the underlying bill H.R. 3617.
  Mr. Speaker, I rise also to speak in strong support of the Rule 
governing House consideration of H.R. 6833, the Affordable Insulin Now 
Act.
  The Rule that is being considered is well crafted and provides 
Members of the House an opportunity to address an urgent need of 
constituents who require life saving insulin.
  The bill is simple and gets to the urgent need to limit cost-sharing 
for insulin under private health insurance and the Medicare 
prescription drug benefit.
  Specifically, the bill caps cost-sharing under private health 
insurance for a month's supply of selected insulin products at $35 or 
25 percent of a plan's negotiated price (after any price concessions), 
whichever is less, beginning in 2023.
  The bill caps cost-sharing under the Medicare prescription drug 
benefit for insulin products at: $35 in 2023 regardless of whether a 
beneficiary has reached the annual out-of-pocket spending threshold, 
and $35 beginning in 2024 for those who have not yet reached this 
threshold.
  The Rule provides for debate and full consideration of the benefits 
offered by H.R. 6833 by the Congress.
  The subject of the bill is public knowledge and well known by members 
of this body.
  I have worked closely with the healthcare community that serve 
Houstonians to ensure that programs are receiving the appropriate level 
of federal support.
  One of the most difficult challenges are the hurdles to healthcare 
created by lack of health insurance such as a lack of access to 
necessary medications due to the high costs of many prescription drugs.
  Diabetes is a life-threatening disease that disproportionately 
affects communities of color.
  Diabetes is associated with serious health problems, including heart 
disease and stroke, kidney failure, and blindness.
  There are 15,000 Medicare beneficiaries in the Eighteenth 
Congressional District who have been diagnosed with diabetes.
  These individuals are my constituents and I know that on average, 
each of them pays 4.8 times the cost of similar medication in 
Australia, 3.6 times the cost in the United Kingdom, and 2.6 times the 
cost in Canada.
  Additionally, in the Eighteenth Congressional District, 26.7 percent 
of residents are uninsured.
  For example, an uninsured resident of this congressional district 
pays 23 times more for this brand of insulin than their counterparts in 
Australia, 15 times more than they would in the United Kingdom, and 13 
times more than they would in Canada.
  The consequences of these staggering costs are not benign.
  Many patients often speak of having to make heart-wrenching decisions 
about what to buy with the commonly fixed incomes attendant to seniors.
  Many medical professionals indicate that the high prices for 
prescription drugs are a function of a lack of competition, and 
authorizing Medicare to create a program to negotiate drug prices may 
be an estimable way to lower the cost of prescription drugs.
  All told this reflects a disturbing trend: in our country, the cost 
of branded drugs tends to go up, whereas in other countries, the costs 
tend to go down.
  Before insulin the prognosis for diabetics was bleak.
  Over the past two decades, manufacturers have systematically and 
dramatically raised the prices of their insulin products by more than 
tenfold--often in lockstep.
  In 2017, diabetes contributed to the death of 277,000 Americans--and 
was the primary death for 85,000 of those individuals.
  That same year diagnosed diabetes cost the United States an estimated 
$327 billion--including $237 billion in direct medical costs and $90 
billion in productivity losses.
  Diabetes drugs, including insulin and oral medications that regulate 
blood sugar levels, play a critical role in helping people with 
diabetes manage their condition and reduce the risk of diabetes-related 
health complications.
  Although insulin is the most well-known diabetes medication, diabetes 
patients are often prescribed other oral drugs to use in place of or 
alongside insulin.
  Many of these non-insulin products used to regulate blood sugar 
levels are brand drugs that lack generic alternatives.
  In recent years, the high prices of diabetes drugs have placed a 
tremendous strain on diabetes patients as well as the federal 
government, which provides diabetes medications to more than 43 million 
Medicare beneficiaries.
  Because Medicare lacks the authority to negotiate directly with drug 
manufacturers, Medicare beneficiaries pay significantly more for their 
drugs than patients abroad.
  Patients who are uninsured or underinsured and must pay for their 
drugs out of pocket bear an even greater cost burden.
  The Rule allows the House to address this urgent need by voting on 
H.R. 6833.
  I thank the committees on Energy and Commerce, Ways and Means, and 
Education and Labor for the work they have done to bring H.R. 6833, the 
Affordable Insulin Now Act to the floor for a vote.
  I encourage my colleagues on both sides of the aisle to vote in 
support of the Rule and the underlying bill H.R. 6833.
  Thank you.

                              {time}  1315

  Mrs. FISCHBACH. Mr. Speaker, the American people should be asking--
no, they should be demanding--that this body address energy 
independence. But the majority refuses to hear or even discuss the 
Republican solution that we have been talking about. Instead, we do 
have before us today a bill to legalize pot.

[[Page H4030]]

  Mr. Speaker, I yield 2 minutes to the gentleman from Wisconsin (Mr. 
Tiffany).
  Mr. TIFFANY. Mr. Speaker, I rise in opposition to the MORE 
legislation both for what it does and what it does not do.
  For starters, the bill authorizes the collection of detailed 
demographic information on marijuana-sector employees, including their 
race and ethnicity, for a massive, publicly accessible government 
database. This is another attempt by Democrats to promote their 
destructive identity politics agenda and lay the groundwork for a rigid 
quota system that picks winners and losers based on skin color.
  The database will also put more sensitive personal data at risk and 
open the door to mischief by Federal bureaucrats who have repeatedly 
weaponized access to Americans' private information to promote a 
partisan political agenda. Hello IRS.
  I am also disappointed that the majority refused to allow votes on 
two commonsense amendments I proposed. The first would have required 
child-resistant packaging and a Surgeon General's warning label 
detailing the dangers these products pose to pregnant women and their 
unborn babies. Investigative reports have revealed multiple instances 
of pot shop clerks recommending marijuana to expectant mothers as safe, 
despite well-documented risks. Few, if any, of these retail clerks have 
any medical training and should stick to dispensing pot, not prenatal 
advice.
  The second would have banned the use of ingredients or flavor 
additives in marijuana-infused products such as fruit, chocolate, 
vanilla, or candy. For years, we have been told by many on the other 
side that such flavors appeal to children and should be banned from 
tobacco products. If this standard is good enough for JUUL and Puff 
Bar, shouldn't it also apply to Cheech and Chong?
  Mr. Speaker, this legislation will make an already complicated 
situation worse. I ask for a ``no'' vote on the rule and a ``no'' vote 
on the bill.
  Mr. PERLMUTTER. Mr. Speaker, I just remind my friend from Wisconsin 
that 47 States, every territory, and the District of Columbia now allow 
for some level of marijuana use, and this Congress is going to have to 
catch up to what the States are doing.
  Mr. Speaker, I yield 1 minute to the gentlewoman from California (Ms. 
Pelosi).
  Ms. PELOSI. Mr. Speaker, I thank the gentleman for yielding, and I 
thank him for his leadership in bringing this important legislation to 
the floor.
  Mr. Speaker, in his outstanding State of the Union Address earlier 
this month, President Joe Biden presented Democrats' visionary agenda 
to build a better America with lower healthcare costs for American 
families, and with justice in all that we do.
  House Democrats have long led the charge to lower the costs of 
prescription drugs. So it is with great pride that the Democratic House 
today will advance one of the pillars of this vision: capping the cost 
of insulin at $35 a month. In doing so, we take another important step 
in the fight to bring down drug prices across the board for every 
American family.
  I thank the lead sponsors of this legislation who have been 
relentless, dissatisfied, and persistent in this fight: Congresswoman 
Angie Craig, Congressman  Dan Kildee, and Congresswoman Lucy McBath of 
Georgia.
  I salute the chairs of the committees of jurisdiction for helping 
steer this vital legislation to the floor: Chairman Frank Pallone of 
the Committee on Energy and Commerce, Chairman Richie Neal of the 
Committee on Ways and Means, and Chairman  Bobby Scott of the Committee 
on Education and Labor.
  Everyone knows that the cost of insulin--a lifesaving drug that has 
been around for a century--is outrageous and out of control. That cost 
is outrageous and out of control. On average, Americans pay more than 
10 times for insulin compared to what consumers around the world pay. 
Here in the United States the price of insulin skyrocketed by 54 
percent from 2014 to 2019. Meanwhile, Big Pharma is reaping record-
breaking profits; producing insulin at about $10 a vial, while charging 
families up to 30 times that amount.
  This affordability crisis is taking a severe human toll. One in four 
Americans who rely on insulin have been forced to ration or skip their 
dose--a practice that can be dangerous and even deadly. And working 
parents with a family member on insulin are reporting higher levels of 
stress and anxiety and are often forced to choose between paying their 
bills and protecting the health of a loved one.
  Indeed, across the country, as I have said on this floor before, I 
have seen grown men cry about how they cannot meet their family's needs 
when it comes to prescription drugs. This crisis is a kitchen-table 
issue for millions of families, and it is a medical, economic, and 
moral imperative that Congress take action.
  The Affordable Insulin Now Act not only requires Medicare and 
commercial users to cover lifesaving insulin on their plans, but also 
caps the out-of-pocket costs for families at $35 per month. In doing 
so, we put more money back in the pockets of hardworking families and 
vulnerable seniors. This is crucial right now, as so many Americans 
struggle to keep up with the burdensome, everyday costs. Of course, 
this has even been exacerbated with COVID which has, in many instances, 
spread diabetes more.
  House Democrats proudly passed a cap on insulin's cost in the Build 
Back Better legislation last year. We already did this last year. 
Today, we, again, take this strong step toward lower health costs for 
the people. To be clear, comprehensive reform is urgently needed to 
lift the crushing burden of prescription drug prices weighing on our 
families.
  Democrats will never ever relent, Mr. Speaker, until we realize our 
longstanding goal of lowering drug prices across the board. And we are 
continuing our fight to empower Medicare to negotiate lower drug 
prices--we have been working on that for decades--and make these lower 
prices available to Americans with private insurance, too.

  We do so in honor of the late Chairman Elijah Cummings, the North 
Star in Congress and a relentless warrior for lower drug prices, with 
the Lower Drug Costs Now Act.
  Mr. Speaker, as you know, this rule applies not just to lowering the 
cost of insulin but also to the very important MORE Act.
  I also rise today in support of this urgent legislation that will 
help pave the path toward racial and economic justice.
  I thank Chairman Jerry Nadler for his steadfast voice for equity and 
opportunity for all at the helm of the Judiciary Committee.
  I salute Congressman Ed Perlmutter for his tireless and longstanding 
leadership on this issue, a relentless persistence to satisfy, as the 
gentleman says. Thank heaven, we are passing it today.
  I also want to commend Congresswoman Barbara Lee and Congressman Earl 
Blumenauer for their persistence as well.
  For far too long, Mr. Speaker, failed Federal drug policies have torn 
apart families and devastated communities of color. People of color are 
four times more likely to be arrested on cannabis charges and are often 
targeted for longer prison terms than others. Tragically, the 
communities most harmed by criminalization are benefiting the least 
from the legal cannabis marketplace as prior cannabis convictions are 
barring too many of them from entering the industry. As a result, only 
one-fifth of cannabis businesses are minority owned, and only 4 percent 
of owners are Black. Meanwhile, more than 600,000 Americans are still 
arrested each year on cannabis charges, threatening to perpetuate this 
vicious cycle.
  With the MORE Act, which the Democratic House proudly passed last 
Congress, we take strong actions to correct these injustices.
  This landmark legislation is one of the most important criminal 
justice reform bills in recent history: delivering justice for those 
harmed by the brutal and unfair consequences of criminalization; 
opening the doors of opportunity for all to participate in this rapidly 
growing industry; and decriminalizing cannabis at the Federal level so 
we do not repeat the grave mistakes of our past.
  Those of us from California take pride in our State's long leadership 
in this justice effort, and in recent years,

[[Page H4031]]

46 more States have reformed cannabis laws. As the distinguished 
gentleman from Colorado mentioned in his remarks, 47 States have taken 
this act. Now it is time for the Federal Government to follow suit.
  Both of the bills that the House will pass today that are covered by 
this rule, the insulin bill and the MORE Act, are overwhelmingly 
popular with the American people, and they represent strong steps 
toward building a brighter and fairer future for our children.
  Mr. Speaker, I urge strong, bipartisan ``yes'' votes on both bills 
and on the rule.
  Mrs. FISCHBACH. Mr. Speaker, I yield 2 minutes to the gentleman from 
Minnesota (Mr. Stauber).
  Mr. STAUBER. Mr. Speaker, as a law enforcement officer for over 23 
years, I have had to make the devastating visit to unsuspecting family 
members to tell them that their loved one has died because a driver was 
driving under the influence. We can all sit here and pretend that 
marijuana is a harmless drug, but it is not. It clouds your judgment 
and inhibits your reaction time.
  The unfortunate reality is if we take steps to legalize marijuana, we 
will, without question, increase the number of people who will drive 
under the influence of marijuana on our roads. As we know all too well, 
there are many angel families in this country who have lost their sons 
and daughters to people who are unlawfully in this country and drove 
under the influence.
  My amendment would have ensured the MORE Act does not prohibit the 
deportation of illegal immigrants who are convicted of driving under 
the influence of marijuana. Unfortunately, Democrats blocked my 
commonsense and potentially lifesaving amendment.
  Mr. Speaker, shouldn't we, at a minimum, ensure this legislation is 
not weaponized and used as a tool to get criminals who are in this 
country illegally out of trouble and out of deportation proceedings?
  It seems to me that the safety of the American people continues to be 
a low priority for this Democrat majority.
  Mr. Speaker, I ask my colleagues to vote ``no'' on the rule.
  Mr. PERLMUTTER. Mr. Speaker, I ask my friend from Minnesota if she 
has any other speakers.
  Mrs. FISCHBACH. No, I do not, and I am prepared to close.
  Mr. PERLMUTTER. Mr. Speaker, I reserve the balance of my time.
  Mrs. FISCHBACH. Mr. Speaker, I yield myself the balance of my time.
  Mr. Speaker, I continue to be disappointed in the priorities of my 
colleagues. They have chosen to spend precious time that could be spent 
addressing the national debt, inflation, gas prices, or any number of 
serious issues facing Americans today. Instead, they chose to talk 
about legalizing marijuana and spending tax dollars on pot stores--
which does not take into consideration important elements like how to 
protect minors or how to address laws surrounding driving under the 
influence--and an insincere attempt to address the rising cost of 
insulin.
  Mr. Speaker, I oppose the rule and the underlying bills, I ask 
Members to do the same, and I yield back the balance of my time.
  Mr. PERLMUTTER. Mr. Speaker, how much time do I have remaining?
  The SPEAKER pro tempore. The gentleman from Colorado has 3 minutes 
remaining.
  Mr. PERLMUTTER. Mr. Speaker, I yield myself the remainder of my time.
  Mr. Speaker, I want to thank my colleagues for joining me here today 
to speak on the rule, the MORE Act, and the Affordable Insulin Now Act. 
I especially want to thank Mr. Nadler, Ms. Lee, and Mr. Blumenauer with 
respect to the MORE Act.
  Data is clear that patients in the United States pay more than 10 
times for their insulin than what patients in other countries pay for 
this lifesaving drug. There are reports of people paying up to $1,000 a 
month just to keep themselves alive. Nobody should face these kinds of 
difficult decisions about affording their medication and keeping 
themselves healthy or putting food on the table.
  The Affordable Insulin Now Act puts a reasonable cap of $35 a month 
on this important drug, and I hope we can advance this bipartisan idea 
this week.

                              {time}  1330

  On marijuana, we are long past due for the reforms in the MORE Act. 
The MORE Act is about justice, safety, equity, and States' rights. We 
must decriminalize marijuana at the Federal level and take meaningful 
steps to address the effects the war on drugs has had, particularly in 
minority and disadvantaged communities.
  To my friends on the other side of the aisle who claim this isn't an 
important issue to American families, I encourage them to talk to 
individuals who can't pass a background check to get a job, visit with 
people who spent time in prison for a low-level marijuana conviction 
whose lives have been changed forever, talk to a State-legal business 
owner or employee who faces armed robberies or threats of violence due 
to all the cash they have since the business can't access the banking 
system.
  The House is acting again this week to urge the Senate to finally 
pass meaningful cannabis reform legislation. As this body knows, my 
SAFE Banking Act has passed the House six times now without any Senate 
action, with big bipartisan numbers. The House will pass the MORE Act 
this week. It is clear Congress needs to reform our broken cannabis 
laws to better respond to the 37 States across the country that have 
some level of legal marijuana use.
  The material previously referred to by Mrs. Fischbach is as follows:

                   Amendment to House Resolution 1017

  At the end of the resolution, add the following:

       Sec. 5. Immediately upon adoption of this resolution, the 
     House shall proceed to the consideration in the House of the 
     bill (H.R. 6858) to strengthen United States energy security, 
     encourage domestic production of crude oil, petroleum 
     products, and natural gas, and for other purposes. All points 
     of order against consideration of the bill are waived. The 
     bill shall be considered as read. All points of order against 
     provisions in the bill are waived. The previous question 
     shall be considered as ordered on the bill and on any 
     amendment thereto to final passage without intervening motion 
     except: (1) one hour of debate equally divided and controlled 
     by the chair and ranking minority member of the Committee on 
     Energy and Commerce; and (2) one motion to recommit.
       Sec. 6. Clause 1(c) of rule XIX shall not apply to the 
     consideration of H.R. 6858.

  Mr. PERLMUTTER. Mr. Speaker, I encourage a ``yes'' vote on the rule 
and the previous question.
  Mr. Speaker, I yield back the balance of my time, and I move the 
previous question on the resolution.
  The SPEAKER pro tempore. The question is on ordering the previous 
question.
  The question was taken; and the Speaker pro tempore announced that 
the ayes appeared to have it.
  Mrs. FISCHBACH. Mr. Speaker, on that I demand the yeas and nays.
  The SPEAKER pro tempore. Pursuant to section 3(s) of House Resolution 
8, the yeas and nays are ordered.
  The vote was taken by electronic device, and there were--yeas 219, 
nays 202, not voting 10, as follows:

                             [Roll No. 98]

                               YEAS--219

     Adams
     Aguilar
     Allred
     Auchincloss
     Axne
     Barragan
     Bass
     Beatty
     Bera
     Beyer
     Bishop (GA)
     Blumenauer
     Blunt Rochester
     Bonamici
     Bourdeaux
     Bowman
     Boyle, Brendan F.
     Brown (MD)
     Brown (OH)
     Brownley
     Bush
     Butterfield
     Carbajal
     Cardenas
     Carson
     Carter (LA)
     Cartwright
     Case
     Casten
     Castor (FL)
     Castro (TX)
     Cherfilus-McCormick
     Chu
     Cicilline
     Clark (MA)
     Clarke (NY)
     Cleaver
     Clyburn
     Cohen
     Connolly
     Cooper
     Correa
     Costa
     Courtney
     Craig
     Crist
     Crow
     Cuellar
     Davids (KS)
     Davis, Danny K.
     Dean
     DeFazio
     DeGette
     DeLauro
     DelBene
     Delgado
     Demings
     DeSaulnier
     Deutch
     Dingell
     Doggett
     Doyle, Michael F.
     Escobar
     Eshoo
     Espaillat
     Evans
     Fletcher
     Foster
     Frankel, Lois
     Gaetz
     Gallego
     Garamendi
     Garcia (IL)
     Garcia (TX)
     Golden
     Gomez
     Gonzalez, Vicente
     Gottheimer
     Green, Al (TX)
     Grijalva
     Harder (CA)
     Hayes
     Higgins (NY)
     Himes
     Horsford
     Houlahan
     Hoyer
     Huffman
     Jackson Lee
     Jacobs (CA)
     Jayapal
     Jeffries
     Johnson (GA)
     Johnson (TX)
     Jones
     Kahele
     Kaptur
     Keating
     Kelly (IL)
     Khanna
     Kildee
     Kilmer
     Kim (NJ)
     Kind
     Kirkpatrick
     Krishnamoorthi
     Kuster
     Lamb
     Langevin
     Larsen (WA)
     Larson (CT)
     Lawrence
     Lawson (FL)
     Lee (CA)
     Lee (NV)
     Leger Fernandez
     Levin (CA)
     Levin (MI)
     Lieu
     Lofgren
     Lowenthal
     Luria
     Lynch
     Malinowski

[[Page H4032]]


     Maloney, Carolyn B.
     Maloney, Sean
     Manning
     Matsui
     McBath
     McCollum
     McEachin
     McGovern
     McNerney
     Meeks
     Meng
     Mfume
     Morelle
     Moulton
     Mrvan
     Murphy (FL)
     Nadler
     Napolitano
     Neal
     Neguse
     Newman
     Norcross
     O'Halleran
     Ocasio-Cortez
     Omar
     Pallone
     Panetta
     Pappas
     Pascrell
     Payne
     Perlmutter
     Peters
     Phillips
     Pingree
     Pocan
     Porter
     Pressley
     Price (NC)
     Quigley
     Raskin
     Rice (NY)
     Ross
     Roybal-Allard
     Ruiz
     Ruppersberger
     Rush
     Ryan
     Sanchez
     Sarbanes
     Scanlon
     Schakowsky
     Schiff
     Schneider
     Schrader
     Schrier
     Scott (VA)
     Scott, David
     Sewell
     Sherman
     Sherrill
     Sires
     Slotkin
     Smith (WA)
     Soto
     Spanberger
     Speier
     Stansbury
     Stanton
     Stevens
     Strickland
     Suozzi
     Swalwell
     Takano
     Thompson (CA)
     Thompson (MS)
     Titus
     Tlaib
     Torres (CA)
     Torres (NY)
     Trahan
     Trone
     Underwood
     Vargas
     Veasey
     Vela
     Velazquez
     Wasserman Schultz
     Waters
     Watson Coleman
     Welch
     Wexton
     Wild
     Williams (GA)
     Wilson (FL)
     Yarmuth

                               NAYS--202

     Aderholt
     Allen
     Amodei
     Arrington
     Babin
     Bacon
     Baird
     Balderson
     Banks
     Barr
     Bentz
     Bergman
     Bice (OK)
     Biggs
     Bilirakis
     Bishop (NC)
     Boebert
     Bost
     Brooks
     Buchanan
     Buck
     Bucshon
     Budd
     Burchett
     Burgess
     Calvert
     Cammack
     Carey
     Carl
     Carter (GA)
     Carter (TX)
     Cawthorn
     Chabot
     Cline
     Cloud
     Clyde
     Cole
     Comer
     Crawford
     Crenshaw
     Curtis
     Davidson
     DesJarlais
     Diaz-Balart
     Donalds
     Duncan
     Dunn
     Ellzey
     Emmer
     Estes
     Fallon
     Feenstra
     Ferguson
     Fischbach
     Fitzgerald
     Fitzpatrick
     Fleischmann
     Foxx
     Franklin, C. Scott
     Fulcher
     Gallagher
     Garbarino
     Garcia (CA)
     Gibbs
     Gimenez
     Gohmert
     Gonzales, Tony
     Gonzalez (OH)
     Good (VA)
     Gooden (TX)
     Gosar
     Granger
     Graves (LA)
     Graves (MO)
     Green (TN)
     Greene (GA)
     Griffith
     Grothman
     Guest
     Guthrie
     Harris
     Harshbarger
     Hern
     Herrell
     Herrera Beutler
     Hice (GA)
     Higgins (LA)
     Hill
     Hinson
     Hollingsworth
     Hudson
     Huizenga
     Issa
     Jackson
     Jacobs (NY)
     Johnson (LA)
     Johnson (OH)
     Johnson (SD)
     Jordan
     Joyce (OH)
     Joyce (PA)
     Katko
     Keller
     Kelly (MS)
     Kelly (PA)
     Kim (CA)
     Kustoff
     LaHood
     LaMalfa
     Lamborn
     Latta
     LaTurner
     Lesko
     Letlow
     Long
     Loudermilk
     Lucas
     Luetkemeyer
     Mace
     Malliotakis
     Mann
     Massie
     Mast
     McCarthy
     McCaul
     McClain
     McClintock
     McHenry
     McKinley
     Meijer
     Meuser
     Miller (IL)
     Miller (WV)
     Miller-Meeks
     Moolenaar
     Mooney
     Moore (AL)
     Moore (UT)
     Mullin
     Murphy (NC)
     Nehls
     Newhouse
     Norman
     Obernolte
     Owens
     Palazzo
     Palmer
     Pence
     Perry
     Pfluger
     Posey
     Reed
     Reschenthaler
     Rice (SC)
     Rodgers (WA)
     Rogers (AL)
     Rogers (KY)
     Rose
     Rosendale
     Rouzer
     Roy
     Rutherford
     Salazar
     Scalise
     Schweikert
     Scott, Austin
     Sessions
     Simpson
     Smith (MO)
     Smith (NE)
     Smith (NJ)
     Smucker
     Spartz
     Stauber
     Steel
     Stefanik
     Steil
     Steube
     Stewart
     Taylor
     Tenney
     Thompson (PA)
     Tiffany
     Timmons
     Turner
     Upton
     Valadao
     Van Drew
     Van Duyne
     Wagner
     Walberg
     Walorski
     Waltz
     Weber (TX)
     Webster (FL)
     Wenstrup
     Westerman
     Williams (TX)
     Wilson (SC)
     Wittman
     Womack
     Zeldin

                             NOT VOTING--10

     Armstrong
     Brady
     Bustos
     Cheney
     Davis, Rodney
     Fortenberry
     Hartzler
     Kinzinger
     Moore (WI)
     Tonko

                              {time}  1406

  Messrs. JACOBS of New York, STEWART, COLE, NEWHOUSE, LAMBORN, WILSON 
of South Carolina, and SMITH of Missouri changed their vote from 
``yea'' to ``nay.''
  Mr. McEACHIN changed his vote from ``nay'' to ``yea.''
  So the previous question was ordered.
  The result of the vote was announced as above recorded.
  Stated against:
  Mr. RODNEY DAVIS of Illinois. I was unavoidably detained. Had I been 
present, I would have voted ``nay'' on rollcall No. 98.


    Members Recorded Pursuant to House Resolution 8, 117th Congress

     Baird (Walorski)
     Bilirakis (Fleischmann)
     Bowman (Meng)
     Cawthorn (Nehls)
     Comer (Fleischmann)
     Crist (Wasserman Schultz)
     Cuellar (Pappas)
     Curtis (Stewart)
     DeGette (Blunt Rochester)
     Espaillat (Correa)
     Harder (CA) (Gomez)
     Jayapal (Gomez)
     Johnson (TX) (Jeffries)
     Joyce (OH) (Garbarino)
     Kahele (Mrvan)
     Krishnamoorthi (Beyer)
     Lawson (FL) (Wasserman Schultz)
     Mace (Rice (SC))
     Manning (Beyer)
     McClain (Fitzgerald)
     Newman (Beyer)
     Owens (Stewart)
     Roybal-Allard (Wasserman Schultz)
     Salazar (Gimenez)
     Sanchez (Gomez)
     Scott, David (Jeffries)
     Sessions (Babin)
     Sires (Pallone)
     Soto (Wasserman Schultz)
     Steel (Obernolte)
     Strickland (Takano)
     Suozzi (Beyer)
     Taylor (Carter (TX))
     Thompson (MS) (Evans)
     Trone (Beyer)
     Waltz (Mast)
     Wilson (FL) (Jeffries)
  The SPEAKER pro tempore. The question is on the resolution.
  The question was taken; and the Speaker pro tempore announced that 
the ayes appeared to have it.
  Mrs. FISCHBACH. Mr. Speaker, on that I demand the yeas and nays.
  The SPEAKER pro tempore. Pursuant to section 3(s) of House Resolution 
8, the yeas and nays are ordered.
  The vote was taken by electronic device, and there were--yeas 219, 
nays 202, not voting 10, as follows:

                             [Roll No. 99]

                               YEAS--219

     Adams
     Aguilar
     Allred
     Auchincloss
     Axne
     Barragan
     Bass
     Beatty
     Bera
     Beyer
     Bishop (GA)
     Blumenauer
     Blunt Rochester
     Bonamici
     Bourdeaux
     Bowman
     Boyle, Brendan F.
     Brown (MD)
     Brown (OH)
     Brownley
     Bush
     Butterfield
     Carbajal
     Cardenas
     Carson
     Carter (LA)
     Cartwright
     Case
     Casten
     Castor (FL)
     Castro (TX)
     Cherfilus-McCormick
     Chu
     Cicilline
     Clark (MA)
     Clarke (NY)
     Cleaver
     Clyburn
     Cohen
     Connolly
     Cooper
     Correa
     Costa
     Courtney
     Craig
     Crist
     Crow
     Cuellar
     Davids (KS)
     Davis, Danny K.
     Dean
     DeFazio
     DeGette
     DeLauro
     DelBene
     Delgado
     Demings
     DeSaulnier
     Deutch
     Dingell
     Doggett
     Doyle, Michael F.
     Escobar
     Eshoo
     Espaillat
     Evans
     Fletcher
     Foster
     Frankel, Lois
     Gallego
     Garamendi
     Garcia (IL)
     Garcia (TX)
     Golden
     Gomez
     Gonzalez, Vicente
     Gottheimer
     Green, Al (TX)
     Grijalva
     Harder (CA)
     Hayes
     Higgins (NY)
     Himes
     Horsford
     Houlahan
     Hoyer
     Huffman
     Jackson Lee
     Jacobs (CA)
     Jayapal
     Jeffries
     Johnson (GA)
     Johnson (TX)
     Jones
     Kahele
     Kaptur
     Keating
     Kelly (IL)
     Khanna
     Kildee
     Kilmer
     Kim (NJ)
     Kind
     Kirkpatrick
     Krishnamoorthi
     Kuster
     Lamb
     Langevin
     Larsen (WA)
     Larson (CT)
     Lawrence
     Lawson (FL)
     Lee (CA)
     Lee (NV)
     Leger Fernandez
     Levin (CA)
     Levin (MI)
     Lieu
     Lofgren
     Lowenthal
     Luria
     Lynch
     Malinowski
     Maloney, Carolyn B.
     Maloney, Sean
     Manning
     Matsui
     McBath
     McCollum
     McEachin
     McGovern
     McNerney
     Meeks
     Meng
     Mfume
     Moore (WI)
     Morelle
     Moulton
     Mrvan
     Murphy (FL)
     Nadler
     Napolitano
     Neal
     Neguse
     Newman
     Norcross
     O'Halleran
     Ocasio-Cortez
     Omar
     Pallone
     Panetta
     Pappas
     Pascrell
     Payne
     Perlmutter
     Peters
     Phillips
     Pingree
     Pocan
     Porter
     Pressley
     Price (NC)
     Quigley
     Raskin
     Rice (NY)
     Ross
     Roybal-Allard
     Ruiz
     Ruppersberger
     Rush
     Ryan
     Sanchez
     Sarbanes
     Scanlon
     Schakowsky
     Schiff
     Schneider
     Schrader
     Schrier
     Scott (VA)
     Scott, David
     Sewell
     Sherman
     Sherrill
     Sires
     Slotkin
     Smith (WA)
     Soto
     Spanberger
     Speier
     Stansbury
     Stanton
     Stevens
     Strickland
     Suozzi
     Swalwell
     Takano
     Thompson (CA)
     Thompson (MS)
     Titus
     Tlaib
     Torres (CA)
     Torres (NY)
     Trahan
     Trone
     Underwood
     Vargas
     Veasey
     Vela
     Velazquez
     Wasserman Schultz
     Waters
     Watson Coleman
     Welch
     Wexton
     Wild
     Williams (GA)
     Wilson (FL)
     Yarmuth

                               NAYS--202

     Aderholt
     Allen
     Amodei
     Arrington
     Babin
     Bacon
     Baird
     Balderson
     Banks
     Barr
     Bentz
     Bergman
     Bice (OK)
     Biggs
     Bilirakis
     Bishop (NC)
     Boebert
     Bost
     Brooks
     Buchanan
     Buck
     Bucshon
     Budd
     Burchett
     Burgess
     Calvert
     Cammack
     Carey
     Carl
     Carter (GA)
     Carter (TX)
     Cawthorn
     Chabot
     Cline
     Cloud
     Clyde
     Cole
     Comer
     Crawford
     Crenshaw
     Curtis
     Davidson
     Davis, Rodney
     DesJarlais
     Diaz-Balart
     Donalds
     Duncan
     Dunn
     Ellzey
     Emmer
     Estes
     Fallon
     Feenstra
     Ferguson
     Fischbach
     Fitzgerald
     Fitzpatrick
     Fleischmann
     Foxx
     Franklin, C. Scott
     Fulcher
     Gaetz
     Gallagher
     Garbarino
     Garcia (CA)
     Gibbs
     Gimenez
     Gohmert
     Gonzales, Tony
     Gonzalez (OH)
     Good (VA)
     Gooden (TX)
     Gosar
     Granger
     Graves (LA)
     Graves (MO)
     Green (TN)
     Greene (GA)
     Griffith
     Grothman
     Guest
     Guthrie
     Harris
     Harshbarger
     Hern
     Herrell
     Herrera Beutler
     Hice (GA)
     Higgins (LA)
     Hill
     Hinson
     Hudson
     Huizenga
     Issa
     Jackson
     Jacobs (NY)
     Johnson (LA)
     Johnson (OH)
     Johnson (SD)
     Jordan
     Joyce (OH)
     Joyce (PA)
     Katko
     Keller
     Kelly (MS)
     Kelly (PA)
     Kim (CA)
     Kustoff
     LaHood
     LaMalfa
     Lamborn
     Latta
     LaTurner
     Lesko
     Letlow
     Long
     Loudermilk
     Lucas
     Luetkemeyer
     Mace
     Malliotakis
     Mann
     Massie
     Mast
     McCarthy
     McCaul
     McClain
     McClintock
     McHenry
     McKinley
     Meijer
     Meuser
     Miller (IL)
     Miller (WV)
     Miller-Meeks
     Moolenaar
     Mooney

[[Page H4033]]


     Moore (AL)
     Moore (UT)
     Mullin
     Murphy (NC)
     Nehls
     Newhouse
     Norman
     Obernolte
     Owens
     Palazzo
     Palmer
     Pence
     Perry
     Pfluger
     Posey
     Reed
     Reschenthaler
     Rice (SC)
     Rodgers (WA)
     Rogers (AL)
     Rogers (KY)
     Rose
     Rosendale
     Rouzer
     Roy
     Rutherford
     Salazar
     Scalise
     Schweikert
     Scott, Austin
     Sessions
     Simpson
     Smith (MO)
     Smith (NE)
     Smith (NJ)
     Smucker
     Spartz
     Stauber
     Steel
     Stefanik
     Steil
     Steube
     Stewart
     Taylor
     Tenney
     Thompson (PA)
     Tiffany
     Timmons
     Turner
     Upton
     Valadao
     Van Drew
     Van Duyne
     Wagner
     Walberg
     Walorski
     Waltz
     Weber (TX)
     Webster (FL)
     Wenstrup
     Westerman
     Williams (TX)
     Wilson (SC)
     Wittman
     Womack

                             NOT VOTING--10

     Armstrong
     Brady
     Bustos
     Cheney
     Fortenberry
     Hartzler
     Hollingsworth
     Kinzinger
     Tonko
     Zeldin

                              {time}  1417

  So the resolution was agreed to.
  The result of the vote was announced as above recorded.
  A motion to reconsider was laid on the table.


                          PERSONAL EXPLANATION

  Mr. TONKO. Madam Speaker, I was detained by legislative business. Had 
I been present, I would have voted ``yea'' on rollcall No. 98 and 
``yea'' on rollcall No. 99.


    Members Recorded Pursuant to House Resolution 8, 117th Congress

     Baird (Walorski)
     Bilirakis (Fleischmann)
     Bowman (Meng)
     Cawthorn (Nehls)
     Comer (Fleischmann)
     Crist (Wasserman Schultz)
     Cuellar (Pappas)
     Curtis (Stewart)
     DeGette (Blunt Rochester)
     Espaillat (Correa)
     Harder (CA) (Gomez)
     Jayapal (Gomez)
     Johnson (TX) (Jeffries)
     Joyce (OH) (Garbarino)
     Kahele (Mrvan)
     Krishnamoorthi (Beyer)
     Lawson (FL) (Wasserman Schultz)
     Mace (Rice (SC))
     Manning (Beyer)
     McClain (Fitzgerald)
     Newman (Beyer)
     Owens (Stewart)
     Roybal-Allard (Wasserman Schultz)
     Salazar (Gimenez)
     Sanchez (Gomez)
     Scott, David (Jeffries)
     Sessions (Babin)
     Sires (Pallone)
     Soto (Wasserman Schultz)
     Steel (Obernolte)
     Strickland (Takano)
     Suozzi (Beyer)
     Taylor (Carter (TX))
     Thompson (MS) (Evans)
     Trone (Beyer)
     Waltz (Mast)
     Wilson (FL) (Jeffries)

                          ____________________